Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs Rivaroxaban for VTE Prophylaxis in TKA
NCT02271399Phase 2Completed
- Sponsor
- Hanyang University
- Start
- Oct 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rivaroxaban in venous thromboembolism (VTE), sponsored by Hanyang University. Started Oct 2014; status: completed.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02271399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271399.